Evaluation of a Biobehavioral Intervention for Hot Flashes
Objectives:
I. To evaluate the effect of hypnosis plus venlafaxine versus focused attention with
venlafaxine versus hypnosis plus a placebo versus focused attention plus a placebo for
reducing hot flashes.
II. To evaluate the side effects associated with hypnosis with venlafaxine versus focused
attention with venlafaxine versus hypnosis plus a placebo versus focused attention plus a
placebo for reducing hot flashes.
III. To evaluate the effects of the four treatment arms on mood, sleep, hot flash
interference and menopause quality of life.
IV. To explore the role of expectancy and hypnotizability as moderators of the effect of
each of the four treatment arms in reducing hot flashes.
Outline: Patients are randomized to 1 of 4 intervention arms. Patients receive oral
venlafaxine or a placebo and practice hypnosis or focused attention.
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Hot flash score, frequency, and severity
No
Debra L. Barton, R.N., Ph.D.
Principal Investigator
Mayo Clinic
United States: Federal Government
MC09C7
NCT01000623
November 2009
January 2014
Name | Location |
---|---|
Mayo Clinic | Rochester, Minnesota 55905 |